GLP-1 Drugs Linked to Better Cancer Outcomes, Study Finds (ca.news.yahoo.com)

• GLP-1 drugs associated with lower cancer mortality and recurrence
• Over 1.6 million patient records analyzed
• Causal link not confirmed; further trials needed

"A large observational study suggests that GLP-1 receptor agonists (e.g., Ozempic) may improve cancer outcomes, including lower mortality and reduced recurrence risk. The study analyzed data from over 1.6 million patients and found associations particularly for obesity-related cancers. However, causality is not proven, and randomized trials are needed. The findings were published in JAMA Network Open."